Skip to Content

Fidelity Advisor Health Care M FACTX

Medalist Rating as of | See Fidelity Investment Hub
  • NAV / 1-Day Return 58.33  /  +1.43 %
  • Total Assets 5.0 Bil
  • Adj. Expense Ratio
    1.230%
  • Expense Ratio 1.230%
  • Distribution Fee Level Average
  • Share Class Type Front Load
  • Category Health
  • Investment Style Large Growth
  • Min. Initial Investment
  • Status Open
  • TTM Yield
  • Turnover 47%

USD | NAV as of Mar 28, 2024 | 1-Day Return as of Mar 28, 2024, 10:12 PM GMT+0

Morningstar’s Analysis FACTX

Will FACTX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A standout on several fronts.

Strategist Robby Greengold

Robby Greengold

Strategist

Summary

Fidelity’s Health Care Sector strategy, which includes Fidelity Select Health Care and Fidelity Advisor Health Care, has the ingredients it needs for long-term success.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FACTX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 55.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Boston Scientific Corp

9.95 480.8 Mil
Healthcare

Eli Lilly and Co

8.02 387.4 Mil
Healthcare

UnitedHealth Group Inc

7.10 342.9 Mil
Healthcare

Danaher Corp

6.66 321.5 Mil
Healthcare

Merck & Co Inc

4.75 229.5 Mil
Healthcare

Regeneron Pharmaceuticals Inc

4.59 221.6 Mil
Healthcare

Penumbra Inc

4.10 198.0 Mil
Healthcare

CVS Health Corp

3.77 182.2 Mil
Healthcare

The Cigna Group

3.55 171.5 Mil
Healthcare

Thermo Fisher Scientific Inc

2.79 134.7 Mil
Healthcare